Regulatory Due Diligence Could Offset Foreign Manufacturing Cost-Savings
This article was originally published in The Tan Sheet
Executive Summary
Companies that seek to save costs by manufacturing products outside the U.S. might in some cases pay a price to come into regulatory compliance for the U.S. market, FDA executives caution